These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 11093618)

  • 21. Pathology of Natural Cases of Equine Endocrinopathic Laminitis Associated With Hyperinsulinemia.
    Karikoski NP; McGowan CM; Singer ER; Asplin KE; Tulamo RM; Patterson-Kane JC
    Vet Pathol; 2015 Sep; 52(5):945-56. PubMed ID: 25232034
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Circulating miR-23b-3p, miR-145-5p and miR-200b-3p are potential biomarkers to monitor acute pain associated with laminitis in horses.
    Lecchi C; Dalla Costa E; Lebelt D; Ferrante V; Canali E; Ceciliani F; Stucke D; Minero M
    Animal; 2018 Feb; 12(2):366-375. PubMed ID: 28689512
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Basement membrane pathology: a feature of acute equine laminitis.
    Pollitt CC
    Equine Vet J; 1996 Jan; 28(1):38-46. PubMed ID: 8565952
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Equine laminitis: cryotherapy reduces the severity of the acute lesion.
    van Eps AW; Pollitt CC
    Equine Vet J; 2004 Apr; 36(3):255-60. PubMed ID: 15147134
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of systemic immunologic hyperreactivity after intradermal testing in horses with chronic laminitis.
    Wagner IP; Rees CA; Dunstan RW; Credille KM; Hood DM
    Am J Vet Res; 2003 Mar; 64(3):279-83. PubMed ID: 12661866
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lamellar pathology in horses with pituitary pars intermedia dysfunction.
    Karikoski NP; Patterson-Kane JC; Singer ER; McFarlane D; McGowan CM
    Equine Vet J; 2016 Jul; 48(4):472-8. PubMed ID: 25869529
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plasma concentrations of inflammatory markers in previously laminitic ponies.
    Wray H; Elliott J; Bailey SR; Harris PA; Menzies-Gow NJ
    Equine Vet J; 2013 Sep; 45(5):546-51. PubMed ID: 23418944
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Submural histopathologic changes attributable to peracute laminitis in horses.
    Morgan SJ; Hood DM; Wagner IP; Postl SP
    Am J Vet Res; 2003 Jul; 64(7):829-34. PubMed ID: 12856766
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intestinal bacterial overgrowth includes potential pathogens in the carbohydrate overload models of equine acute laminitis.
    Onishi JC; Park JW; Prado J; Eades SC; Mirza MH; Fugaro MN; Häggblom MM; Reinemeyer CR
    Vet Microbiol; 2012 Oct; 159(3-4):354-63. PubMed ID: 22633481
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activation of extracellular matrix metalloproteinases in equine laminitis.
    Johnson PJ; Tyagi SC; Katwa LC; Ganjam VK; Moore LA; Kreeger JM; Messer NT
    Vet Rec; 1998 Apr; 142(15):392-6. PubMed ID: 9586131
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ultrastructural examination of basement membrane pathology in horses with insulin-induced laminitis.
    de Laat MA; Pollitt CC
    Domest Anim Endocrinol; 2019 Oct; 69():30-34. PubMed ID: 31280023
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The developmental and acute phases of insulin-induced laminitis involve minimal metalloproteinase activity.
    de Laat MA; Kyaw-Tanner MT; Nourian AR; McGowan CM; Sillence MN; Pollitt CC
    Vet Immunol Immunopathol; 2011 Apr; 140(3-4):275-81. PubMed ID: 21333362
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Equine laminitis model: lamellar histopathology seven days after induction with oligofructose.
    Van Eps AW; Pollitt CC
    Equine Vet J; 2009 Nov; 41(8):735-40. PubMed ID: 20095219
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased plasma fructosamine concentrations in laminitic horses.
    Knowles EJ; Withers JM; Mair TS
    Equine Vet J; 2012 Mar; 44(2):226-9. PubMed ID: 21696439
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Glucocorticoids and laminitis in the horse.
    Johnson PJ; Slight SH; Ganjam VK; Kreeger JM
    Vet Clin North Am Equine Pract; 2002 Aug; 18(2):219-36. PubMed ID: 15635906
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Continuous digital hypothermia initiated after the onset of lameness prevents lamellar failure in the oligofructose laminitis model.
    van Eps AW; Pollitt CC; Underwood C; Medina-Torres CE; Goodwin WA; Belknap JK
    Equine Vet J; 2014 Sep; 46(5):625-30. PubMed ID: 24004323
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Decreased expression of p63, a regulator of epidermal stem cells, in the chronic laminitic equine hoof.
    Carter RA; Engiles JB; Megee SO; Senoo M; Galantino-Homer HL
    Equine Vet J; 2011 Sep; 43(5):543-51. PubMed ID: 21496086
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vivo priming and ex vivo activation of equine neutrophils in black walnut extract-induced equine laminitis is not attenuated by systemic lidocaine administration.
    Loftus JP; Williams JM; Belknap JK; Black SJ
    Vet Immunol Immunopathol; 2010 Nov; 138(1-2):60-9. PubMed ID: 20667603
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Histopathology of insulin-induced laminitis in ponies.
    Asplin KE; Patterson-Kane JC; Sillence MN; Pollitt CC; Mc Gowan CM
    Equine Vet J; 2010 Nov; 42(8):700-6. PubMed ID: 21039799
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Decision-tree analysis of clinical data to aid diagnostic reasoning for equine laminitis: a cross-sectional study.
    Wylie CE; Shaw DJ; Verheyen KL; Newton JR
    Vet Rec; 2016 Apr; 178(17):420. PubMed ID: 26969668
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.